Summit Therapeutics Inc. (SMMT)
NASDAQ: SMMT · Real-Time Price · USD
13.92
+0.30 (2.20%)
Sep 1, 2026, 11:02 AM EDT - Market open

Summit Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-856.09-1,080-221.32-614.93-78.78-88.6
Depreciation & Amortization
0.170.150.090.21.262.46
Loss (Gain) From Sale of Assets
----0.11--
Asset Writedown & Restructuring Costs
--15.01521.398.47-
Loss (Gain) From Sale of Investments
-10.2-7.01-2.58-1.92--
Stock-Based Compensation
384.04732.4250.9814.1111.9512.8
Other Operating Activities
0.36-0.320.235.025.650.82
Change in Accounts Receivable
----0.98-1.14
Change in Accounts Payable
-0.0915.32.022.26-4.13-1.71
Change in Unearned Revenue
-----7.28-0.81
Change in Other Net Operating Assets
23.3716.1113.46-2.7820.33.6
Operating Cash Flow
-458.43-322.93-142.11-76.76-41.58-72.59
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-1.39-0.66-0.14-0.13-0.62-0.31
Sale of Property, Plant & Equipment
---0.23--
Sale (Purchase) of Intangibles
---15.01-475.02--
Investment in Securities
-261.18-173.65-190.2-112.86--
Investing Cash Flow
-262.57-174.31-205.34-587.77-0.62-0.31

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-----110
Long-Term Debt Issued
----545-
Total Debt Issued
----545110
Short-Term Debt Repaid
------110
Long-Term Debt Repaid
---100-24.69-25-
Total Debt Repaid
---100-24.69-25-110
Net Debt Issued (Repaid)
---100-24.69520-
Issuance of Common Stock
842.51617.53481.23111.82100.478.09
Other Financing Activities
----0.62-0.16-0.17
Financing Cash Flow
842.51617.53381.2386.51620.2477.92

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.020.1-0.020.84-1.220.35
Net Cash Flow
121.49120.433.76-577.18576.825.37

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-459.82-323.59-142.25-76.89-42.21-72.89
Free Cash Flow Growth
------
Free Cash Flow Margin
-----5986.67%-4029.46%
Free Cash Flow Per Share
-0.60-0.43-0.20-0.12-0.22-0.79
Levered Free Cash Flow
-139.6884.08-88.94-221.68-319.72-38.3
Unlevered Free Cash Flow
-139.6884.08-83.51-211.39-316.97-38.15

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
--8.8110.650.430.09
Cash Income Tax Paid
---0.05--
Change in Working Capital
23.2931.4215.48-0.529.87-0.07
SEC Filings: 10-K · 10-Q